July 11, 2017
It’s been over a year since the launch of former vice president Joe Biden’s Cancer Moonshot, designed to spur innovation and encourage collaboration on finding cures for cancer. So now, patients, physicians, researchers and policymakers are pausing to ask: Are we any closer?
June 14, 2017
Clinical pathways in the age of personalized cancer care may be excluding a key component: patient perspective.
May 25, 2017
Is precision medicine gaining traction in the field of oncology? The Food and Drug Administration’s recent approval of the cancer drug pembrolizumab offers a hint.
April 13, 2017
What is good value in terms of cancer treatment? The question, amid rising cancer care costs, has prompted a surge of oncology value models in recent years.
April 10, 2017
Physicians and patients are no longer asking if a biological medicine is the best choice, but – more likely – which biological medicine is the best choice. This opening thought from Alliance for Patient Access Chairman David Charles, MD, set the tone for the organization’s second annual National Policy and Advocacy Summit on Biologics and Biosimilars, held Thursday in Washington, DC.
April 1, 2017
Cancer treatment is better than ever before, thanks in part to more effective medications. But these medications often carry high…
February 7, 2017
More patients are living longer with cancer – and that’s good news. But some face policies, health care providers and workplaces that are unprepared to support survivors. So explained a February webinar, “Global Cancer Survivorship: The Need for Integrative Care,” sponsored by Bristol-Myers Squibb.
January 10, 2017
About 83 percent of Americans say they could depend upon their health insurer if diagnosed with a serious illness like cancer, according to Aimed Alliance polling.
December 16, 2016
Hepatitis C patients keep waiting…and waiting…and waiting.
October 18, 2016
Breast Cancer Awareness Month, celebrated this October, invites public dialogue about screening, risk factors and the value of early detection.
